Got Proteasomes?

Photo: Courtesy of Boston Biochem PURITY CHECK: Boston Biochem CEO Francesco Melandri (right) and research associate Nick Crawford assess the purity of a protein using SDS-PAGE. Researchers expend a lot of energy studying gene and protein expression. But what happens when the proteins are no longer needed? In the late 1980s Alfred L. Goldberg, professor of cell biology at Harvard Medical School, and Martin C. Rechsteiner, professor of biochemistry at the University of Utah, addressed thi

Written byLaura Lane
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Researchers expend a lot of energy studying gene and protein expression. But what happens when the proteins are no longer needed? In the late 1980s Alfred L. Goldberg, professor of cell biology at Harvard Medical School, and Martin C. Rechsteiner, professor of biochemistry at the University of Utah, addressed this question when they discovered proteasomes--large, multienzyme complexes that play a key role in protein breakdown. Their work challenged the assumption that lysosomes were the primary cellular "chop shops" responsible for digesting proteins that the cell no longer needed; indeed, proteasomes degrade the bulk of these proteins.

The average human cell contains about 30,000 proteasomes, each of which contains several protein-digesting proteases. These complexes help regulate a whole host of functions including transcription, viral infection, oncogenesis, cell cycle, stress response, ribosome biogenesis, abnormal protein catabolism, neural and muscular degeneration, antigen processing, DNA repair, and cellular differentiation, says Francesco Melandri, chief executive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies